ATE421093T1 - Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten - Google Patents

Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Info

Publication number
ATE421093T1
ATE421093T1 AT04787562T AT04787562T ATE421093T1 AT E421093 T1 ATE421093 T1 AT E421093T1 AT 04787562 T AT04787562 T AT 04787562T AT 04787562 T AT04787562 T AT 04787562T AT E421093 T1 ATE421093 T1 AT E421093T1
Authority
AT
Austria
Prior art keywords
hgf
growth factor
different forms
body fluid
rapid determination
Prior art date
Application number
AT04787562T
Other languages
English (en)
Inventor
Fariba Nayeri
Tayeb Nayeri
Original Assignee
Peas Inst Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peas Inst Ab filed Critical Peas Inst Ab
Application granted granted Critical
Publication of ATE421093T1 publication Critical patent/ATE421093T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04787562T 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten ATE421093T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50719203P 2003-09-29 2003-09-29

Publications (1)

Publication Number Publication Date
ATE421093T1 true ATE421093T1 (de) 2009-01-15

Family

ID=34393223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787562T ATE421093T1 (de) 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Country Status (7)

Country Link
US (1) US20070224703A1 (de)
EP (1) EP1687636B1 (de)
AT (1) ATE421093T1 (de)
DE (1) DE602004019134D1 (de)
DK (1) DK1687636T3 (de)
ES (1) ES2321105T3 (de)
WO (1) WO2005031365A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007110698A2 (en) * 2005-11-16 2007-10-04 Fariba Nayeri Methods for inhibiting carcinogenesis and/or metastasis in an individual with endogenous c-met ligands and inhibitors
CN104330574B (zh) 2008-11-10 2017-04-12 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
US9157920B2 (en) 2009-06-26 2015-10-13 Peas Institut Ab Method for determining biologically active HGF
EP3095876A1 (de) 2010-11-02 2016-11-23 Kypha, Inc. Querfluss-immuntest für komplement-aktivierung und verfahren zur verwendung zur prüfung auf komplement-assoziierte erkrankungen am versorgungsort
US8865164B2 (en) 2010-11-02 2014-10-21 Kypha, Inc. Detecting complement activation
JP6119607B2 (ja) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
SE536400C2 (sv) * 2012-02-22 2013-10-08 Peas Inst Ab Ny metod för snabb detektion av hepatocyttillväxtfaktor i biologiska vätskor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321488C (en) * 1987-08-22 1993-08-24 Martin Francis Finlan Biological sensors
US5648273A (en) * 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
US5656443A (en) * 1994-07-29 1997-08-12 Long Island Jewish Medical Center Method of diagnosing bladder cancer
JP2002515724A (ja) * 1995-06-01 2002-05-28 ダナ−ファーバー キャンサー インスティテュート インコーポレイテッド ヒト血清中に見出されたジペプチジルペプチダーゼｉｖ（ｃｄ２６）の新規形態、その抗体および利用法
WO1997009997A1 (en) * 1995-09-12 1997-03-20 Genentech, Inc. Cystic fibrosis therapy
US5827673A (en) * 1996-08-13 1998-10-27 Akira Matsumori Method of detecting myocardial infarction
AU784359B2 (en) * 1999-12-15 2006-03-16 Entremed, Inc Compositions and methods for inhibiting endothelial cell proliferation
EP1840575A1 (de) * 2000-08-28 2007-10-03 Damavand Wound AB Kit zur Bestimmung von HGF
US20020115224A1 (en) * 2001-02-16 2002-08-22 Ulrich Rudel Method for the preparation of optical (bio)chemical sensor devices
US6730487B2 (en) * 2001-04-03 2004-05-04 Trustees Of Columbia University In The City Of New York Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy

Also Published As

Publication number Publication date
DK1687636T3 (da) 2009-05-11
US20070224703A1 (en) 2007-09-27
ES2321105T3 (es) 2009-06-02
WO2005031365A3 (en) 2005-07-07
EP1687636B1 (de) 2009-01-14
DE602004019134D1 (de) 2009-03-05
WO2005031365A2 (en) 2005-04-07
EP1687636A2 (de) 2006-08-09

Similar Documents

Publication Publication Date Title
WO2006126008A3 (en) Improved immunoassay methods
ATE410687T1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
DE69530861D1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
DE69917051D1 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
NO20000970L (no) Fremgangsmõte og utstyr for rask analyse av analytter i biologiske stikkprøver
ATE485514T1 (de) Immunoassay mit mehreren analyten
RU2011125320A (ru) Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
ATE499607T1 (de) Analytentestsystem unter verwendung nichtenzymatischer analytenerkennungselemente
ATE514092T1 (de) Vorrichtung und verfahren zur simultanen bestimmung von blutgruppenantigenen
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
ATE478337T1 (de) Methoden zum nachweis analyten in proben
DE602004019134D1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
DE60219642D1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
WO2002077645A3 (en) Method for the measurement of soluble analytes
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
DE69928125D1 (de) EIN VERFAHREN ZUM AUFFINDEN UND/ODER QUANTIFIZIEREN EINES SPEZIFISCHEN IgE-ANTIKÖRPERS IN EINER FLÜSSIGEN PROBE
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE466884T1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
ES2108754T3 (es) Medio de soporte.
ATE360206T1 (de) Verfahren zur messung der gesamkonzentration eines analytes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1687636

Country of ref document: EP